Bausch & Lomb Clarifies Reporting Of Fusarium Keratitis Cases To FDA

ROCHESTER, N.Y.--(BUSINESS WIRE)--May 17, 2006--Bausch & Lomb wishes to clarify information contained in media reports about the U.S. Food and Drug Administration's inspection of Bausch & Lomb's manufacturing plant and distribution facility in Greenville, S.C., that erroneously suggest that Bausch & Lomb withheld from FDA information the Company received about Fusarium infections in Singapore.

Back to news